Wugen
720
Volume
+99X+
Growth
exploding
About the Topic
Biotechnology company specializing in clinical-stage immuno-oncology cell therapies. It focuses on developing off-the-shelf NK (Natural Killer) and CAR-T (Chimeric Antigen Receptor T-cell) cell therapies for treating solid tumors and hematologic malignancies, differentiating itself by using cells from healthy donors. The primary beneficiaries of Wugen's therapies are patients suffering from various types of cancer.
Wugen was discovered on July 31st 2021 and it currently has a search volume of 720 with a growth of +186%.
Key Indicators
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.